文献速递浆细胞疾病

左旋天冬酰胺酶耗竭氨基酸使多发性骨髓瘤细胞对卡非佐米敏感

Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death.
PubMed 文献 · Blood Adv · 2020-01-01

研究探讨左旋天冬酰胺酶(ASNase)联合卡非佐米对多发性骨髓瘤(MM)细胞的作用。DNA甲基化状态与ASNase相关基因表达降低显著相关,提示MM对ASNase敏感。Erw-ASNase与卡非佐米联合在MM细胞中显示显著协同效应,正常外周血单个核细胞不受影响,该效应与活性氧增加、线粒体损伤及Nrf2上调相关,且卡非佐米耐药细胞对Erw-ASNase更敏感。

要点

  • MM细胞DNA甲基化状态与ASNase相关基因表达降低显著相关
  • Erw-ASNase联合卡非佐米对MM细胞有显著协同效应且不损伤正常PBMC
  • 卡非佐米耐药细胞对Erw-ASNase敏感性高于同源对照细胞

核心结论

  • Erw-ASNase通过影响多种细胞程序使MM细胞对卡非佐米更脆弱,为临床联合增强PI敏感性提供概念验证。

研究设计与样本

  • 研究在MM细胞中检测DNA甲基化与ASNase相关基因表达关联,并测试Erwinia chrysanthemi来源ASNase联合卡非佐米的效应,同时比较正常外周血单个核细胞及卡非佐米耐药与同源细胞。

主要发现

  • Erw-ASNase联合卡非佐米对MM细胞显示显著协同效应,而正常外周血单个核细胞不受影响。
  • 该效应与活性氧生成增加、线粒体损伤加重及Nrf2上调相关,且不依赖c-Myc致癌特异性程序。
  • 联合处理通过增加线粒体氧化应激导致基因组不稳定和DNA修复机制受损,进一步增强抗肿瘤活性。
  • 卡非佐米耐药细胞对Erw-ASNase敏感性高于同源细胞,反映其高度依赖氨基酸饥饿。

临床怎么用

  • Erw-ASNase联合卡非佐米可能作为增强MM患者PI敏感性的新策略,尤其值得在卡非佐米耐药背景下探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolic reprogramming is emerging as a cancer vulnerability that could be therapeutically exploitable using different approaches, including amino acid depletion for those tumors that rely on exogenous amino acids for their maintenance. ʟ-Asparaginase (ASNase) has contributed to a significant improvement in acute lymphoblastic leukemia outcomes; however, toxicity and resistance limit its clinical use in other tumors. Here, we report that, in multiple myeloma (MM) cells, the DNA methylation status is significantly associated with reduced expression of ASNase-related gene signatures, thus suggesting ASNase sensitivity for this tumor. Therefore, we tested the effects of ASNase purified from Erwinia chrysanthemi (Erw-ASNase), combined with the next-generation proteasome inhibitor (PI) carfilzomib. We observed an impressive synergistic effect on MM cells, whereas normal peripheral blood mononuclear cells were not affected. Importantly, this effect was associated with increased reactive oxygen species (ROS) generation, compounded mitochondrial damage, and Nrf2 upregulation, regardless of the c-Myc oncogenic-specific program. Furthermore, the cotreatment resulted in genomic instability and DNA repair mechanism impairment via increased mitochondrial oxidative stress, which further enhanced its antitumor activity. Interestingly, carfilzomib-resistant cells were found to be highly dependent on amino acid starvation, as reflected by their higher sensitivity to Erw-ASNase treatment compared with isogenic cells. Overall, by affecting several cellular programs, Erw-ASNase makes MM cells more vulnerable to carfilzomib, providing proof of concept for clinical use of this combination as a novel strategy to enhance PI sensitivity in MM patients.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Soncini D, Minetto P, Martinuzzi C, et al. Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death. Blood Adv. 2020. PMID: 32915979. doi:10.1182/bloodadvances.2020001639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。